Zemiglo Uses, Dosage, Side Effects and more
Zemiglo is under investigation in Type 2 Diabetes Mellitus. Zemiglo has been investigated for the treatment of Cancer and Cisplatin Adverse Reaction.
| Trade Name | Zemiglo |
| Generic | Gemigliptin |
| Gemigliptin Other Names | Gemigliptin |
| Weight | 50mg |
| Type | Tablet |
| Formula | C18H19F8N5O2 |
| Weight | Average: 489.37 Monoisotopic: 489.141100176 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | Sanofi |
| Available Country | India |
| Last Updated: | January 7, 2025 at 1:49 am |
Uses
Zemiglo is a dipeptidyl peptidase-4 (DPP-4) inhibitor used to manage hyperglycemia in patients with type 2 diabetes mellitus.
Zemiglo is also used to associated treatment for these conditions: Type 2 Diabetes Mellitus
